Benzyl Isothiocyanate As an Adjuvant Chemotherapy Option for Head and Neck Squamous Cell Carcinoma Mary Allison Wolf [email protected]

Total Page:16

File Type:pdf, Size:1020Kb

Benzyl Isothiocyanate As an Adjuvant Chemotherapy Option for Head and Neck Squamous Cell Carcinoma Mary Allison Wolf Teter6@Marshall.Edu Marshall University Marshall Digital Scholar Theses, Dissertations and Capstones 2014 Benzyl Isothiocyanate as an Adjuvant Chemotherapy Option for Head and Neck Squamous Cell Carcinoma Mary Allison Wolf [email protected] Follow this and additional works at: http://mds.marshall.edu/etd Part of the Biological Phenomena, Cell Phenomena, and Immunity Commons, Medical Biochemistry Commons, Medical Cell Biology Commons, and the Oncology Commons Recommended Citation Wolf, Mary Allison, "Benzyl Isothiocyanate as an Adjuvant Chemotherapy Option for Head and Neck Squamous Cell Carcinoma" (2014). Theses, Dissertations and Capstones. Paper 801. This Dissertation is brought to you for free and open access by Marshall Digital Scholar. It has been accepted for inclusion in Theses, Dissertations and Capstones by an authorized administrator of Marshall Digital Scholar. For more information, please contact [email protected]. Benzyl Isothiocyanate as an Adjuvant Chemotherapy Option for Head and Neck Squamous Cell Carcinoma A dissertation submitted to the Graduate College of Marshall University In partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biomedical Sciences By Mary Allison Wolf Approved by Pier Paolo Claudio, M.D., Ph.D., Committee Chairperson Richard Egleton, Ph.D. W. Elaine Hardman, Ph.D. Jagan Valluri, Ph.D. Hongwei Yu, PhD Marshall University May 2014 DEDICATION “I sustain myself with the love of family”—Maya Angelou To my wonderful husband, loving parents, and beautiful daughter—thank you for everything you have given me. ii ACKNOWLEDGEMENTS First and foremost, I would like to thank my mentor Dr. Pier Paolo Claudio. He has instilled in me the skills necessary to become an independent and successful researcher. I will always be grateful for his guidance and support during each step of my studies and I value everything he has taught me over the years. I would also like to acknowledge the current and past lab members of the Claudio Lab: Dr. Flavia De Carlo, Miranda Carper, Sarah Mathis, Oksana Bailiff, Rounak Nande, Dr. Ilaria Naldi, Benji Pyles, and Colleen Conlon. Each of these individuals has contributed to my success in some way, and I am fortunate to have been given the opportunity to work alongside them. I would particularly like to recognize Dr. Flavia De Carlo and Miranda Carper for their guidance, input, and support throughout my time at Marshall. Their work ethic and drive have been truly inspirational to me and I cherish the lifelong friendship that has developed. I am also thankful for the members of McKown Translational Genomic Research Institute: Dr. Johannes Fahrmann, Dr. Sarah Miles, Ted Witte, Dr. Gabriella Ion, and Margaret McFarland. It has been a pleasure to work with such great individuals. I would especially like to recognize Dr. Johannes Fahrmann for all of his support. He was always available to help me troubleshoot problems and understand my data. He has a true passion for research and will make an amazing Principle Investigator. I am also appreciative of the guidance I received from Dr. Heath Damron. I would never have started down this path without him. His love for research is contagious, and I am thankful to have him as one of my first mentors. Dr. Anne Silvis has also been an excellent mentor. I appreciate all the advice and moral support she has provided with over the past few years. She is a great role model for me in both the research world and life. iii I am also truly grateful for my committee members: Dr. Richard Egleton, Dr. W. Elaine Hardman, Dr. Jagan Valluri, and Dr. Hongwei Yu. Their guidance and expertise have been instrumental to the success of my project. It has been a pleasure and honor to have them guide me through my research career at Marshall. Specials thanks to the Marshall University’s Biomedical Sciences program, especially Dr. Todd Green, Dr. Richard Niles, and Diane Maue. I am so fortunate to have had the opportunity to be a part of this program and I am appreciative of all the support and guidance I have been given since day one. Additional support came from the WV-NASA Space Grant Consortium. I am grateful that, at a time when funding for research continues to be cut, they supported my project. Many students in the state of WV would not be able to continue their studies without this funding. This journey has been anything but easy, and I constantly questioned if I had what it takes to complete the process. I would have thrown in the towel long ago if it had not been for my husband, Chris Wolf. He was my cheerleader and voice of reason, and constantly reminded me that there was a light at the end of the tunnel. Lastly, I would like to thank my daughter, Claire. Her arrival gave me the last bit of motivation I needed to finish this thesis. I want to instill in her the philosophy that you can accomplish anything you put your mind to. iv TABLE OF CONTENTS DEDICATION .......................................................................................................................................... ii ACKNOWLEDGEMENTS ..................................................................................................................... iii LIST OF TABLES ................................................................................................................................. viii LIST OF FIGURES ................................................................................................................................. ix LIST OF ABREVIATIONS .................................................................................................................... xi ABSTRACT ........................................................................................................................................... xiii Chapter 1 : Isothiocyanates Target Carcinogenesis during Tumor Initiation, Promotion, and Progression ...................................................................................................................................... 1 ABSTRACT .............................................................................................................................................. 2 INTRODUCTION .................................................................................................................................... 3 Mechanisms of Action .......................................................................................................................... 7 Uses in Cancer Therapy ...................................................................................................................... 11 Lung Cancer ........................................................................................................................................ 11 Breast Cancer ...................................................................................................................................... 12 Prostate Cancer ................................................................................................................................... 14 Pancreatic Cancer ................................................................................................................................ 15 Hematological Cancer ......................................................................................................................... 16 Head and Neck Cancer ........................................................................................................................ 17 Conclusions ......................................................................................................................................... 19 Chapter 2 : Head and Neck Squamous Cell Carcinoma ............................................................... 20 Epidemiology and Characterization .................................................................................................... 20 Classification and Staging ................................................................................................................... 22 Diagnosis and Treatment .................................................................................................................... 26 Pitfalls of Current Treatments ............................................................................................................. 29 Molecular Mechanisms of HNSCC .................................................................................................... 32 Models used to study HNSCC ............................................................................................................ 33 Chapter 3 : Benzyl Isothiocyanate Inhibits HNSCC Cell Migration and Invasion, and Sensitizes HNSCC Cells to Cisplatin. ........................................................................................................... 37 ABSTRACT ............................................................................................................................................ 38 INTRODUCTION .................................................................................................................................. 39 MATERIALS AND METHODS ............................................................................................................ 41 Materials ............................................................................................................................................. 41 v Cell Culture and Reagents..................................................................................................................
Recommended publications
  • Bioavailability of Sulforaphane from Two Broccoli Sprout Beverages: Results of a Short-Term, Cross-Over Clinical Trial in Qidong, China
    Cancer Prevention Research Article Research Bioavailability of Sulforaphane from Two Broccoli Sprout Beverages: Results of a Short-term, Cross-over Clinical Trial in Qidong, China Patricia A. Egner1, Jian Guo Chen2, Jin Bing Wang2, Yan Wu2, Yan Sun2, Jian Hua Lu2, Jian Zhu2, Yong Hui Zhang2, Yong Sheng Chen2, Marlin D. Friesen1, Lisa P. Jacobson3, Alvaro Muñoz3, Derek Ng3, Geng Sun Qian2, Yuan Rong Zhu2, Tao Yang Chen2, Nigel P. Botting4, Qingzhi Zhang4, Jed W. Fahey5, Paul Talalay5, John D Groopman1, and Thomas W. Kensler1,5,6 Abstract One of several challenges in design of clinical chemoprevention trials is the selection of the dose, formulation, and dose schedule of the intervention agent. Therefore, a cross-over clinical trial was undertaken to compare the bioavailability and tolerability of sulforaphane from two of broccoli sprout–derived beverages: one glucoraphanin-rich (GRR) and the other sulforaphane-rich (SFR). Sulfor- aphane was generated from glucoraphanin contained in GRR by gut microflora or formed by treatment of GRR with myrosinase from daikon (Raphanus sativus) sprouts to provide SFR. Fifty healthy, eligible participants were requested to refrain from crucifer consumption and randomized into two treatment arms. The study design was as follows: 5-day run-in period, 7-day administration of beverages, 5-day washout period, and 7-day administration of the opposite intervention. Isotope dilution mass spectrometry was used to measure levels of glucoraphanin, sulforaphane, and sulforaphane thiol conjugates in urine samples collected daily throughout the study. Bioavailability, as measured by urinary excretion of sulforaphane and its metabolites (in approximately 12-hour collections after dosing), was substantially greater with the SFR (mean ¼ 70%) than with GRR (mean ¼ 5%) beverages.
    [Show full text]
  • Download Product Insert (PDF)
    PRODUCT INFORMATION Glucoraphanin (potassium salt) Item No. 10009445 Formal Name: 1-thio-1-[5-(methylsulfinyl)-N- O (sulfooxy)pentanimidate]-β-D- OH O- glucopyranose, potassium salt O S MF: C H NO S • XK O 12 22 10 3 OH FW: 436.5 O N Purity: ≥95% UV/Vis.: λmax: 225 nm OH S S Supplied as: A crystalline solid OH O Storage: -20°C • XK+ Stability: ≥2 years Information represents the product specifications. Batch specific analytical results are provided on each certificate of analysis. Laboratory Procedures Glucoraphanin (potassium salt) is supplied as a crystalline solid. A stock solution may be made by dissolving the glucoraphanin (potassium salt) in the solvent of choice. Glucoraphanin (potassium salt) is soluble in the organic solvent DMSO, which should be purged with an inert gas, at a concentration of approximately 1 mg/ml. Further dilutions of the stock solution into aqueous buffers or isotonic saline should be made prior to performing biological experiments. Ensure that the residual amount of organic solvent is insignificant, since organic solvents may have physiological effects at low concentrations. Organic solvent-free aqueous solutions of glucoraphanin (potassium salt) can be prepared by directly dissolving the crystalline solid in aqueous buffers. The solubility of glucoraphanin (potassium salt) in PBS, pH 7.2, is approximately 10 mg/ml. We do not recommend storing the aqueous solution for more than one day. Description Glucoraphanin is a natural glycoinsolate found in cruciferous vegetables, including broccoli.1 It is converted to the isothiocyanate sulforaphane by the enzyme myrosinase.1 Sulforaphane has powerful antioxidant, anti-inflammatory, and anti-carcinogenic effects.1,2 It acts by activating nuclear factor erythroid 2-related factor 2 (Nrf2), which induces the expression of phase II detoxification enzymes.3,4 References 1.
    [Show full text]
  • MINI-REVIEW Cruciferous Vegetables: Dietary Phytochemicals for Cancer Prevention
    DOI:http://dx.doi.org/10.7314/APJCP.2013.14.3.1565 Glucosinolates from Cruciferous Vegetables for Cancer Chemoprevention MINI-REVIEW Cruciferous Vegetables: Dietary Phytochemicals for Cancer Prevention Ahmad Faizal Abdull Razis1*, Noramaliza Mohd Noor2 Abstract Relationships between diet and health have attracted attention for centuries; but links between diet and cancer have been a focus only in recent decades. The consumption of diet-containing carcinogens, including polycyclic aromatic hydrocarbons and heterocyclic amines is most closely correlated with increasing cancer risk. Epidemiological evidence strongly suggests that consumption of dietary phytochemicals found in vegetables and fruit can decrease cancer incidence. Among the various vegetables, broccoli and other cruciferous species appear most closely associated with reduced cancer risk in organs such as the colorectum, lung, prostate and breast. The protecting effects against cancer risk have been attributed, at least partly, due to their comparatively high amounts of glucosinolates, which differentiate them from other vegetables. Glucosinolates, a class of sulphur- containing glycosides, present at substantial amounts in cruciferous vegetables, and their breakdown products such as the isothiocyanates, are believed to be responsible for their health benefits. However, the underlying mechanisms responsible for the chemopreventive effect of these compounds are likely to be manifold, possibly concerning very complex interactions, and thus difficult to fully understand. Therefore,
    [Show full text]
  • Volume 73 Some Chemicals That Cause Tumours of the Kidney Or Urinary Bladder in Rodents and Some Other Substances
    WORLD HEALTH ORGANIZATION INTERNATIONAL AGENCY FOR RESEARCH ON CANCER IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC RISKS TO HUMANS VOLUME 73 SOME CHEMICALS THAT CAUSE TUMOURS OF THE KIDNEY OR URINARY BLADDER IN RODENTS AND SOME OTHER SUBSTANCES 1999 IARC LYON FRANCE WORLD HEALTH ORGANIZATION INTERNATIONAL AGENCY FOR RESEARCH ON CANCER IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC RISKS TO HUMANS Some Chemicals that Cause Tumours of the Kidney or Urinary Bladder in Rodents and Some Other Substances VOLUME 73 This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 13–20 October 1998 1999 IARC MONOGRAPHS In 1969, the International Agency for Research on Cancer (IARC) initiated a programme on the evaluation of the carcinogenic risk of chemicals to humans involving the production of critically evaluated monographs on individual chemicals. The programme was subsequently expanded to include evaluations of carcinogenic risks associated with exposures to complex mixtures, life-style factors and biological agents, as well as those in specific occupations. The objective of the programme is to elaborate and publish in the form of monographs critical reviews of data on carcinogenicity for agents to which humans are known to be exposed and on specific exposure situations; to evaluate these data in terms of human risk with the help of international working groups of experts in chemical carcinogenesis and related fields; and to indicate where additional research efforts are needed. The lists of IARC evaluations are regularly updated and are available on Internet: http://www.iarc.fr/.
    [Show full text]
  • Anti-Carcinogenic Glucosinolates in Cruciferous Vegetables and Their Antagonistic Effects on Prevention of Cancers
    molecules Review Anti-Carcinogenic Glucosinolates in Cruciferous Vegetables and Their Antagonistic Effects on Prevention of Cancers Prabhakaran Soundararajan and Jung Sun Kim * Genomics Division, Department of Agricultural Bio-Resources, National Institute of Agricultural Sciences, Rural Development Administration, Wansan-gu, Jeonju 54874, Korea; [email protected] * Correspondence: [email protected] Academic Editor: Gautam Sethi Received: 15 October 2018; Accepted: 13 November 2018; Published: 15 November 2018 Abstract: Glucosinolates (GSL) are naturally occurring β-D-thioglucosides found across the cruciferous vegetables. Core structure formation and side-chain modifications lead to the synthesis of more than 200 types of GSLs in Brassicaceae. Isothiocyanates (ITCs) are chemoprotectives produced as the hydrolyzed product of GSLs by enzyme myrosinase. Benzyl isothiocyanate (BITC), phenethyl isothiocyanate (PEITC) and sulforaphane ([1-isothioyanato-4-(methyl-sulfinyl) butane], SFN) are potential ITCs with efficient therapeutic properties. Beneficial role of BITC, PEITC and SFN was widely studied against various cancers such as breast, brain, blood, bone, colon, gastric, liver, lung, oral, pancreatic, prostate and so forth. Nuclear factor-erythroid 2-related factor-2 (Nrf2) is a key transcription factor limits the tumor progression. Induction of ARE (antioxidant responsive element) and ROS (reactive oxygen species) mediated pathway by Nrf2 controls the activity of nuclear factor-kappaB (NF-κB). NF-κB has a double edged role in the immune system. NF-κB induced during inflammatory is essential for an acute immune process. Meanwhile, hyper activation of NF-κB transcription factors was witnessed in the tumor cells. Antagonistic activity of BITC, PEITC and SFN against cancer was related with the direct/indirect interaction with Nrf2 and NF-κB protein.
    [Show full text]
  • Synthesis of Isothiocyanates Using DMT/NMM/Tso− As a New Desulfurization Reagent
    molecules Article Synthesis of Isothiocyanates Using DMT/NMM/TsO− as a New Desulfurization Reagent Łukasz Janczewski 1,* , Dorota Kr˛egiel 2 and Beata Kolesi ´nska 1 1 Faculty of Chemistry, Institute of Organic Chemistry, Lodz University of Technology, Zeromskiego 116, 90-924 Lodz, Poland; [email protected] 2 Department of Environmental Biotechnology, Faculty of Biotechnology and Food Sciences, Lodz University of Technology, Wolczanska 171/173, 90-924 Lodz, Poland; [email protected] * Correspondence: [email protected] Abstract: Thirty-three alkyl and aryl isothiocyanates, as well as isothiocyanate derivatives from esters of coded amino acids and from esters of unnatural amino acids (6-aminocaproic, 4-(aminomethyl)benzoic, and tranexamic acids), were synthesized with satisfactory or very good yields (25–97%). Synthesis was performed in a “one-pot”, two-step procedure, in the presence of organic base (Et3N, DBU or NMM), and carbon disulfide via dithiocarbamates, with 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4- methylmorpholinium toluene-4-sulfonate (DMT/NMM/TsO−) as a desulfurization reagent. For the synthesis of aliphatic and aromatic isothiocyanates, reactions were carried out in a microwave reactor, and selected alkyl isothiocyanates were also synthesized in aqueous medium with high yields (72–96%). Isothiocyanate derivatives of L- and D-amino acid methyl esters were synthesized, under conditions without microwave radiation assistance, with low racemization (er 99 > 1), and their absolute configuration was confirmed by circular dichroism. Isothiocyanate derivatives of natural and unnatural amino acids were evaluated for antibacterial activity on E. coli and S. aureus bacterial strains, where the Citation: Janczewski, Ł.; Kr˛egiel,D.; most active was ITC 9e.
    [Show full text]
  • Effects of Cruciferous Vegetable Consumption on Urinary
    Cancer Epidemiology, Biomarkers & Prevention 997 Effects of Cruciferous Vegetable Consumption on Urinary Metabolites of the Tobacco-Specific Lung Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in Singapore Chinese Stephen S. Hecht,1 Steven G. Carmella,1 Patrick M.J. Kenney,1 Siew-Hong Low,2 Kazuko Arakawa,3 and Mimi C. Yu3 1University of Minnesota Cancer Center, Minneapolis, Minnesota; 2Department of Community, Occupational, and Family Medicine, National University of Singapore, Singapore; and 3Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California Abstract Vegetable consumption, including cruciferous vegeta- major glucosinolates in seven of the nine cruciferous bles, is protective against lung cancer, but the mechan- vegetables, accounting for 70.0% to 93.2% of all glu- isms are poorly understood. The purpose of this study cosinolates in these vegetables. There was a significant was to investigate the effects of cruciferous vegetable correlation (P = 0.01) between increased consumption consumption on the metabolism of the tobacco-specific of glucobrassicins and decreased levels of NNAL in lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1- urine after adjustment for number of cigarettes smoked butanone (NNK) in smokers. The study was carried out per day; similar trends were observed for NNAL-Glucs in Singapore Chinese, whose mean daily intake of (P = 0.08) and NNAL plus NNAL-Glucs (P = 0.03). cruciferous vegetables is three times greater than that These results are consistent with those of previous of people in the United States. Eighty-four smokers studies, which demonstrate that indole-3-carbinol de- provided urine samples and were interviewed about creases levels of urinary NNAL probably by inducing dietary habits using a structured questionnaire, which hepatic metabolism of NNK.
    [Show full text]
  • Glucoraphanin - an Indirect Antioxidant Found Naturally in Broccoli That Supports Cell Integrity and Protects Against Free Radical Damage by Jeremy Bartos, Ph.D
    GENERAL INFORMATION TM Glucoraphanin - An Indirect Antioxidant Found Naturally In Broccoli That Supports Cell Integrity And Protects Against Free Radical Damage By Jeremy Bartos, Ph.D. Scientific & Regulatory Affairs Manager Glanbia Nutritionals Glanbia Nutritionals | truebroc® White Paper | June 2015 Glanbia Nutritionals | 5951 Mckee rd., Suite 201 | Fitchburg, WI 53719 | 800.336.2183 | 608.316.8500 | www.glanbianutritionals.com TM introduction Today’s health-conscious consumers are more informed and want to WHAT MAKES TRUEBROCTM A PREMIER understand what they are eating as well as the benefits of the products ANTIOXIDANT they consume. They seek natural ingredients that have no additives or preservatives and are botanical or organic in nature. Currently, there are a large volume of products on the market that have an antioxidant health > truebrocTM boosts Phase II Enzymes, enhancing the claim. In 2015 alone almost 1000 new products with an antioxidant body’s own removal of free radicals and overall position have been released1, but how well do they really work? Recent detoxification of cellsNon-burning and non-irritating scientific research on broccoli has revealed a “next generation” antioxidant to the stomach that will potentially change the way we choose and utilize our ingested antioxidants. truebrocTM glucoraphanin, a naturally derived phytonutrient extracted from broccoli seeds, is a rechargeable antioxidant that works > Standardized to 13% glucoraphanin – highest with the body’s own cellular protection system. Currently, the most widely concentration available accepted source of ingested antioxidants are short-term “one and done” antioxidants, such as Vitamins C and E and polyphenols such as > Made from selected natural broccoli seeds grown resveratrol (grapes and wine) and EGCG (green tea) that last for only a in California and water extracted in Canada short time in the body.
    [Show full text]
  • WO 2012/094636 A2 12 July 2012 (12.07.2012) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2012/094636 A2 12 July 2012 (12.07.2012) P O P C T (51) International Patent Classification: S. [US/US]; 12444 Oakfort Place, San Diego, CA 92130 Λ 61Κ 31/4709 (2006.01) A61P 3/04 (2006.01) (US). A61K 31/704 (2006.01) A61P 3/00 (2006.01) (74) Agent: GUISE, Jeffrey W.; Wilson Sonsini Goodrich & A61K 31/7016 (2006.01) A61P 3/10 (2006.01) Rosati, 650 Page Mill Road, Palo Alto, CA 94304-1050 A61K 31/198 (2006.01) A61P 19/10 (2006.01) (US). A61K 31/201 (2006.01) A61P 21/00 (2006.01) A61K 31/353 (2006.01) A61P 37/00 (2006.01) (81) Designated States (unless otherwise indicated, for every A61K 31/155 (2006.01) A61P 1/00 (2006.01) kind of national protection available): AE, AG, AL, AM, A61K 31/7032 (2006.01) A61P 25/24 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, A61K 31/194 (2006.01) A61P 25/22 (2006.01) CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, A61K 31/575 (2006.01) A61P 25/00 (2006.01) DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, A61P 7/12 (2006.01) A61K 31/20 (2006.01) HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, (21) International Application Number: MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, PCT/US20 12/020548 OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, (22) International Filing Date: SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, 6 January 2012 (06.01 .2012) TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]
  • Moringa Spp.) Received: 12 January 2018 Jed W
    www.nature.com/scientificreports OPEN The Diversity of Chemoprotective Glucosinolates in Moringaceae (Moringa spp.) Received: 12 January 2018 Jed W. Fahey 1,2,3,4, Mark E. Olson5,6, Katherine K. Stephenson1,3, Kristina L. Wade1,3, Accepted: 3 May 2018 Gwen M. Chodur 1,4,12, David Odee7, Wasif Nouman8, Michael Massiah9, Jesse Alt10, Published: xx xx xxxx Patricia A. Egner11 & Walter C. Hubbard2 Glucosinolates (GS) are metabolized to isothiocyanates that may enhance human healthspan by protecting against a variety of chronic diseases. Moringa oleifera, the drumstick tree, produces unique GS but little is known about GS variation within M. oleifera, and even less in the 12 other Moringa species, some of which are very rare. We assess leaf, seed, stem, and leaf gland exudate GS content of 12 of the 13 known Moringa species. We describe 2 previously unidentifed GS as major components of 6 species, reporting on the presence of simple alkyl GS in 4 species, which are dominant in M. longituba. We document potent chemoprotective potential in 11 of 12 species, and measure the cytoprotective activity of 6 purifed GS in several cell lines. Some of the unique GS rank with the most powerful known inducers of the phase 2 cytoprotective response. Although extracts of most species induced a robust phase 2 cytoprotective response in cultured cells, one was very low (M. longituba), and by far the highest was M. arborea, a very rare and poorly known species. Our results underscore the importance of Moringa as a chemoprotective resource and the need to survey and conserve its interspecifc diversity.
    [Show full text]
  • University of Florida Thesis Or Dissertation Formatting
    THE EFFECTS OF SOIL TYPE AND NITROGEN RATES ON GLUCOSINOLATE AND OIL PRODUCTION IN BRASSICA CARNATA By THEODOR LINARES STANSLY A THESIS PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE UNIVERSITY OF FLORIDA 2016 © 2016 Theodor Linares Stansly To my parents, Philip and Silvia Stansly, I thank you from the bottom of my heart. Not all of the important lessons needed for a successful career can be taught in schools or universities. They must also come from those who have persevered through life’s obstacles without losing hope, inspiration, and spirit. I am grateful for everything you have done and continue to do throughout these years. ACKNOWLEDGMENTS Many thanks to Pete C. Andersen for allowing me the opportunity to pursue my passion for science and providing the steppingstones to a career as a professional researcher. I also want to thank David Wright, Jim Marois, Sheeja George, and Ramdeo (Andy) Seapaul and the rest of the Brassica carinata research team at the UF North Florida Research and Education Center for all your support and assistance in the development of my project. Mosbah M. Kushad from the University of Illinois and Steven H. Miller at the University of South Florida for assisting in various aspects of data acquisition of the samples. 4 TABLE OF CONTENTS page ACKNOWLEDGMENTS .................................................................................................. 4 LIST OF TABLES ...........................................................................................................
    [Show full text]
  • Broccoli Or Sulforaphane: Is It the Source Or Dose That Matters?
    molecules Review Broccoli or Sulforaphane: Is It the Source or Dose That Matters? Yoko Yagishita 1, Jed W. Fahey 2,3,4, Albena T. Dinkova-Kostova 3,4,5 and Thomas W. Kensler 1,4,* 1 Translational Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; [email protected] 2 Department of Medicine, Division of Clinical Pharmacology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA; [email protected] 3 Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA 4 Cullman Chemoprotection Center, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA 5 Jacqui Wood Cancer Centre, Division of Cellular Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, Scotland DD1 9SY, UK; [email protected] * Correspondence: [email protected]; Tel.: +1-206-667-6005 Academic Editor: Gary D. Stoner Received: 24 September 2019; Accepted: 2 October 2019; Published: 6 October 2019 Abstract: There is robust epidemiological evidence for the beneficial effects of broccoli consumption on health, many of them clearly mediated by the isothiocyanate sulforaphane. Present in the plant as its precursor, glucoraphanin, sulforaphane is formed through the actions of myrosinase, a β-thioglucosidase present in either the plant tissue or the mammalian microbiome. Since first isolated from broccoli and demonstrated to have cancer chemoprotective properties in rats in the early 1990s, over 3000 publications have described its efficacy in rodent disease models, underlying mechanisms of action or, to date, over 50 clinical trials examining pharmacokinetics, pharmacodynamics and disease mitigation. This review evaluates the current state of knowledge regarding the relationships between formulation (e.g., plants, sprouts, beverages, supplements), bioavailability and efficacy, and the doses of glucoraphanin and/or sulforaphane that have been used in pre-clinical and clinical studies.
    [Show full text]